Analysis of age-related changes in psychosine metabolism in the human brain

Autor: Benas Jakubauskas, Michael S. Marshall, Zane Hauck, Lisa DiAntonio, Richard B. van Breemen, Wil Bogue, Monika Stoskute, Ernesto R. Bongarzone, Emily A. Rue, Matthew Nichols, Carlos A. Saavedra-Matiz, Jeffrey H. Kordower
Rok vydání: 2018
Předmět:
Male
Central Nervous System
0301 basic medicine
Aging
Heredity
lcsh:Medicine
Alzheimer's Disease
Nervous System
Cohort Studies
0302 clinical medicine
Medicine and Health Sciences
Aging brain
lcsh:Science
Aged
80 and over

Brain Diseases
Movement Disorders
Multidisciplinary
Mental Disorders
Brain
Parkinson Disease
Neurodegenerative Diseases
Human brain
Middle Aged
3. Good health
Substantia Nigra
medicine.anatomical_structure
Neurology
Cerebral cortex
alpha-Synuclein
Female
Autopsy
Anatomy
Galactosylceramidase
Research Article
Adult
medicine.medical_specialty
Central nervous system
Substantia nigra
Context (language use)
White matter
03 medical and health sciences
Alzheimer Disease
Internal medicine
Mental Health and Psychiatry
Genetics
medicine
Humans
Aged
business.industry
lcsh:R
Psychosine
Biology and Life Sciences
030104 developmental biology
Endocrinology
Mutation
Dementia
lcsh:Q
business
030217 neurology & neurosurgery
Zdroj: PLoS ONE, Vol 13, Iss 2, p e0193438 (2018)
PLoS ONE
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0193438
Popis: α-Synuclein aggregation has been linked to Gaucher’s disease (GD) and Krabbe’s disease (KD), lysosomal conditions affecting glycosphingolipid metabolism. α-Synuclein pathology has been directly attributed to the dysregulation of glycosphingolipids in both conditions, specifically to increased galactosylsphingosine (psychosine) content in the context of KD. Furthermore, the gene (GALC) coding for the psychosine degrading enzyme galactosylceramidase (GALC), has recently been identified as a risk loci for Parkinson’s disease. However, it is unknown if changes in psychosine metabolism and GALC activity in the context of the aging human brain correlate with Parkinson’s disease. We investigated psychosine accumulation and GALC activity in the aging brain using fresh frozen post-mortem tissue from Parkinson’s (PD, n = 10), Alzheimer’s (AD, n = 10), and healthy control patients (n = 9), along with tissue from neuropsychiatric patients (schizophrenia, bipolar disorder and depression, n = 15 each). An expanded mutational analysis of PD (n = 20), AD (n = 10), and healthy controls (n = 30) examined if PD was correlated with carriers for severe GALC mutations. Psychosine content within the cerebral cortex of PD patients was elevated above control patients. Within all patients, psychosine displayed a significant (p
Databáze: OpenAIRE